ReWalk Robotics Ltd. (LFWD)

Market Cap	40.11M
Revenue (ttm)	13.85M
Net Income (ttm)	-22.13M
Shares Out	8.50M
EPS (ttm)	-2.59
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,245
Open	4.860
Previous Close	4.750
Day's Range	4.630 - 4.880
52-Week Range	3.900 - 9.100
Beta	n/a
Analysts	Strong Buy
Price Target	9.00 (+90.68%)
Earnings Date	May 28, 2024

About LFWD

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurolo...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 12, 2014
• Employees: 108
• Stock Exchange: NASDAQ
• Ticker Symbol: LFWD

Financial Performance

In 2023, LFWD's revenue was $13.85 million, an increase of 151.39% compared to the previous year's $5.51 million. Losses were -$22.13 million, 13.1% more than in 2022.

Analyst Forecast

According to one analyst, the rating for LFWD stock is "Strong Buy" and the 12-month stock price forecast is $9.0.

Price Target

$9.0

(90.68% upside)

Analyst Consensus: Strong Buy